NEWS
FOR IMMEDIATE RELEASE
CONTACT:
Audrey Chang,
(202) 295-8779
media@midatlanticbio.org
More than 20 Biotech Companies to Present Business Innovations,
Growth Strategies at Mid-Atlantic Bio
Eighth Regional Gathering of Life Sciences Companies at Every Stage
Bethesda, Maryland (August 17, 2012) – The Mid-Atlantic Bio Conference today
named the more than 20 biotech companies that will formally present business
innovations and growth strategies to an audience of more than 850 investors, scientists,
advisors and professional service providers from the life sciences sector during this
year’s Annual Conference on September 27-28, 2012. Hundreds of biotech companies
from across the industry will be coming together during this regional event.
The 2012 Mid-Atlantic Bio Conference is presented by the Mid-Atlantic Venture
Association, the Virginia Biotechnology Association, the Tech Council of Maryland,
along with their new, strategic partner, the North Carolina Biotechnology Center.
In addition to world-class programming, thought leadership and networking, the MidAtlantic Bio Conference is known for providing growth companies an opportunity to
present before a variety of capital sources, including venture capital, angel and
corporate investors; industry professionals and business leaders; peer scientists; and
potential strategic partners.
“We are looking forward to learning more about these 22 companies and the cuttingedge technologies and breakthroughs they can bring to the table,” said Jeffrey M.
Gallagher Virginia Bio Interim Executive Director and co-host of Mid-Atlantic Bio.
“Bringing these companies together with venture capitalists and other investors is one of
the high points of Mid-Atlantic Bio.”
“The innovations combined with the progress these enterprises are achieving spotlight
the success and advancements the biotech industry is making across our region.
These are science driven, market-based solutions to some of the most important
healthcare challenges we face, both big and small,” Bruce Robertson, Managing
Director of H.I.G. BioVentures.
Following a competitive multi-phase application and review process, the selection
committee of industry investors and advisors chose the following companies, which
specialize in medical devices, diagnostics, healthcare IT and biopharmaceuticals, to
present:
“Emerging Growth” Presenters – are actively seeking investment, but are in earlier
stages of development (up to and including clinical trials when applicable) with
promising technologies or products.












ADial Pharmaceuticals LLC, Charlottesville, VA
Adlyfe, Inc., Rockville, MD
ALung Technologies, Inc., Pittsburgh, PA
Arbovax Inc., Raleigh, NC
Celek Pharmaceuticals LLC, Rockville, MD
Cellphire, Inc., Rockville, MD
MaxCyte, Inc., Gaithersburg, MD
Plasmonix, Inc., Baltimore, MD
Psyadon Pharmaceuticals, Germantown, MD
Suspension Orthopaedic Solutions, Inc., Arnold, MD
Theranostics Health, Inc., Rockville, MD
Xdynia, Charlottesville, VA
“First Look” Presenters – provide a sneak preview at nascent technologies
representing exciting innovations. First Look is designed to shine the light on those
earliest stage firms who are reinventing the world we live in, but who are still building
their tools and technologies.










AllTranz Inc., Baltimore, MD
BOSS Medical LLC, Baltimore, MD
CC Biotech LLC, Rockville, MD
Katharos, Inc., Raleigh, NC
Melanovus Oncology, Inc., Hummelstown, PA
Metabiomics Corp, Potomac Falls, VA
MxBiodevices, LLC, Greenville, NC
Remedium Technologies, Inc., College Park, MD
SynAm Vaccine, Rockville, MD
Trana Discovery, Inc., Cary, NC
More later-stage growth companies will be spotlighted as “Showcase” companies
throughout the program.
“The Mid-Atlantic Bio Conference is a must-attend event for companies wanting to do
business in this region. The life sciences community is heavily represented at the
conference, with a range of companies taking on key roles in the program as well as
actively participating as audience members,” said Julia Spicer, Executive Director of
Mid-Atlantic Venture Association, a co-host of the conference.
The 2012 Mid-Atlantic Bio Conference
Recognized as the premier regional bioscience industry conference, the two-day MidAtlantic Bio Conference presents a comprehensive agenda comprised of policy
discussions, educational workshops, partnering and business development meetings,
investor presentations, media briefings and an exhibition. The event attracts more than
800 national and international industry leaders and stakeholders – including
entrepreneurs, representatives from start-ups, small to midsize and developing
companies, as well as larger established companies, capital sources, researchers and
universities, public policymakers, suppliers and service providers – from approximately
30 states and 10 countries.
Over the course of two days, attendees will engage in company presentations, policy
discussions, educational workshops, partnering and business development meetings,
investor presentations, media briefings and innovation exhibitions.
The event, which is taking place September 27-28 at the Bethesda North Marriott Hotel
& Conference in Bethesda, Maryland, is presented by the Virginia Biotechnology
Association (VABIO), Tech Council of Maryland (TCM), Mid-Atlantic Venture
Association (MAVA) and North Carolina Biotechnology Center. For more information on
the conference program or to register please visit www.midatlanticbio.org.
About Mid-Atlantic Bio
Mid-Atlantic Bio – taking place September 27-28 in Bethesda, Md. – is one of the
country’s premier biotech conferences for senior-level executives, policymakers,
academia, financiers, media and service providers. Its proximity to the US government,
federal labs, commercial research and development, academic centers of excellence
and a growing investment community, make it a uniquely valuable venue for those in
the life sciences community. First launched as an industry gathering at the Academies
of Science, the conference is a joint initiative of the founding host organizations: the
Mid-Atlantic Venture Association, the Virginia Biotechnology Association, and the Tech
Council of Maryland. The Conference is also pleased to welcome the North Carolina
Biotechnology Center as a strategic partner for 2012. For more information, please
visit midatlanticbio.org.
###